NCT02395926 - To Evaluate Safety and the Pharmacokinetic Characteristics After Oral Administration of HT-003 Compared With Choline Alfoscerate Capsule in Healthy Adult Male Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Healthy Male

Interventions

DRUG

Choline CR 600mg

HT-003 600mg, administration 2 times per 1 day 8:00 a.m., 20:00

DRUG

Gliatilin 400mg

Gliatilin soft capsule 400mg, administration 3 times per 1day 8:00 a.m., 14:00, 20:00

DRUG

Choline CR 600mg

HT-003 600mg\*2tab, administration 1 times per 1 day 8:00 a.m.